FOLH1 and prostate cancer: In a pilot study including six biochemically recurrent prostate cancer patients, Minamimoto et al. (2016) compared [68Ga]Ga-PSMA-11 with [68Ga]Ga-RM2, revealing distinctive biodistribution patterns for both tracers.